Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations
- PMID: 16408282
- DOI: 10.1002/mrm.20761
Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations
Abstract
Parkinson's disease (PD) is characterized by loss of dopaminergic neurons in the substantia nigra (SN), the cause of which is unknown. Characterization of early SN pathology could prove beneficial in the treatment and diagnosis of PD. The present study shows that with the use of short-echo (5 ms) Stimulated-Echo Acquisition Mode (STEAM) spectroscopy and LCModel, a neurochemical profile consisting of 10 metabolites, including gamma-aminobutyric acid (GABA), glutamate (Glu), and glutathione (GSH), can be measured from the unilateral SN at 4 tesla. The neurochemical profile of the SN is unique and characterized by a fourfold higher GABA/Glu ratio compared to the cortex, in excellent agreement with established neurochemistry. The presence of elevated GABA levels in SN was validated with the use of editing, suggesting that partial volume effects were greatly reduced. These findings establish the feasibility of obtaining a neurochemical profile of the unilateral human SN by single-voxel spectroscopy in small volumes.
Copyright 2006 Wiley-Liss, Inc.
Similar articles
-
Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.J Neurochem. 2008 May;105(3):874-82. doi: 10.1111/j.1471-4159.2007.05185.x. Epub 2007 Dec 13. J Neurochem. 2008. PMID: 18088356
-
Improved resolution of glutamate, glutamine and γ-aminobutyric acid with optimized point-resolved spectroscopy sequence timings for their simultaneous quantification at 9.4 T.NMR Biomed. 2018 Jan;31(1). doi: 10.1002/nbm.3851. Epub 2017 Nov 3. NMR Biomed. 2018. PMID: 29105187
-
Reproducibility measurement of glutathione, GABA, and glutamate: Towards in vivo neurochemical profiling of multiple sclerosis with MR spectroscopy at 7T.J Magn Reson Imaging. 2017 Jan;45(1):187-198. doi: 10.1002/jmri.25356. Epub 2016 Jun 28. J Magn Reson Imaging. 2017. PMID: 27351712 Free PMC article.
-
Current Practice and New Developments in the Use of In Vivo Magnetic Resonance Spectroscopy for the Assessment of Key Metabolites Implicated in the Pathophysiology of Schizophrenia.Curr Top Med Chem. 2018;18(21):1908-1924. doi: 10.2174/1568026619666181130103559. Curr Top Med Chem. 2018. PMID: 30499397 Review.
-
Precision of metabolite-selective MRS measurements of glutamate, GABA and glutathione: A review of human brain studies.NMR Biomed. 2024 Mar;37(3):e5071. doi: 10.1002/nbm.5071. Epub 2023 Dec 4. NMR Biomed. 2024. PMID: 38050448 Review.
Cited by
-
Simultaneous edited MRS of GABA and glutathione.Neuroimage. 2016 Nov 15;142:576-582. doi: 10.1016/j.neuroimage.2016.07.056. Epub 2016 Aug 14. Neuroimage. 2016. PMID: 27534734 Free PMC article.
-
Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease.Eur Radiol. 2011 Sep;21(9):1962-9. doi: 10.1007/s00330-011-2123-5. Epub 2011 Apr 12. Eur Radiol. 2011. PMID: 21484351
-
A review of the use of magnetic resonance imaging in Parkinson's disease.Ther Adv Neurol Disord. 2014 Jul;7(4):206-20. doi: 10.1177/1756285613511507. Ther Adv Neurol Disord. 2014. PMID: 25002908 Free PMC article. Review.
-
Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.J Neuroimmune Pharmacol. 2013 Jun;8(3):576-93. doi: 10.1007/s11481-013-9460-x. Epub 2013 May 12. J Neuroimmune Pharmacol. 2013. PMID: 23666436 Free PMC article. Review.
-
Current and Emerging MR Methods and Outcome in Rodent Models of Parkinson's Disease: A Review.Front Neurosci. 2021 Apr 7;15:583678. doi: 10.3389/fnins.2021.583678. eCollection 2021. Front Neurosci. 2021. PMID: 33897339 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical